Top Markets
#1 Bitway Bitway +55.02%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +41.19%
#3 Starpower Starpower +37.49%
#4 Pons Pons +34.50%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.80%
#6 aelf aelf +22.66%
#7 SkyAI SkyAI +19.87%
#8 Ocean Protocol Ocean Protocol +18.26%
#9 OpenEden OpenEden +18.13%
#10 Mubarak Mubarak +15.20%
Coin of the day
Bitway Bitway
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Peringkat dalam Saham #29359
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Harga Saham
$0.365
Terakhir disinkronkan: 2025-08-01
Kapitalisasi Pasar
$21.54M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Elevation Oncology, Inc. (ELEV)

Kategori

Healthcare
Riwayat harga saham Elevation Oncology, Inc. (ELEV)
Harga penutupan tertinggi: $0.37 pada 2025-08-01

Harga penutupan terendah: $12.36 pada 2021-06-01
Riwayat harga saham Elevation Oncology, Inc. dari 2021 hingga 2026
Performa harga saham tahunan
Tahun Performa
2025 -40.93%
2024 21.56%
2023 -47.33%
2022 -81.61%
2021 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.55 39.36%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 56.18%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $153.89 451.38%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $117.42 -19.34%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $754.06 8.70%
CH